Baird raised the firm’s price target on Patterson Companies (PDCO) to $31 from $25 and keeps a Neutral rating on the shares. The firm noted they announced today a definitive agreement to be acquired by Patient Square Capital for $31.35 cash per share.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- M&A News: Patterson Companies Stock (PDCO) Rallies on Patient Square Deal
- Albertsons terminates Kroger deal, Macy’s reports Q3 beat: Morning Buzz
- Patterson Companies downgraded to Market Perform from Outperform at Leerink
- Patterson Companies to be acquired by Patient Square for $31.35 per share
- Patterson Companies price target lowered to $24 from $26 at Piper Sandler